Nanoparticles based on gadolinium coordination polymers as highly sensitive T1 MRI contrast agents
US8940275B2 · kind B2 · utility
0Cited by
0References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 8, 2011 |
| Grant date | Jan 27, 2015 |
| Priority date | — |
| Expiry date | Sep 8, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K49/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An agent for imaging of a biological system or delivering drugs to a biological system including one or more nanoparticles formed of at least one gadolinium coordination polymer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.